USANA (USNA) Chief People Officer sells 6,813 shares, retains 5,561

Rhea-AI Filing Summary

USANA Health Sciences executive Paul A. Jones, the company’s Chief People Officer, sold 6,813 shares of Common Stock in an open-market transaction at a price of $18.95 per share.

After this sale, Jones directly holds 5,561 shares of USANA stock, and no derivative positions are shown in this filing.

Insider Trade Summary

Net Seller: 6,813 shares ($129,106)

Net Sell 1 txn

Insider Jones Paul A.

Role CHIEF PEOPLE OFFICER

Sold 6,813 shs ($129K)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,813	$18.95	$129K

Holdings After Transaction: Common Stock — 5,561 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 6,813 shares Sale price: $18.95 per share Shares held after transaction: 5,561 shares

3 metrics

Shares sold 6,813 shares Open-market sale of Common Stock

Sale price $18.95 per share Price for the reported sale

Shares held after transaction 5,561 shares Direct ownership after sale

Key Terms

open-market sale, Common Stock, Form 4

3 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jones Paul A.

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UTAH 84120

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF PEOPLE OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/28/2026		S		6,813	D	$18.95	5,561	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did USANA (USNA) report for Paul A. Jones?

USANA reported that Chief People Officer Paul A. Jones sold 6,813 shares of Common Stock in an open-market transaction. The sale was recorded at a price of $18.95 per share and reflects a direct ownership change.

At what price did Paul A. Jones sell USANA (USNA) shares?

Paul A. Jones sold his USANA Common Stock at $18.95 per share. This price applies to the 6,813 shares sold in the reported open-market transaction on the Form 4 filed for the executive.

How many USANA (USNA) shares does Paul A. Jones hold after the sale?

After the reported sale, Paul A. Jones directly holds 5,561 USANA shares. This post-transaction balance reflects his remaining direct Common Stock ownership as disclosed in the Form 4 filing.

What role does Paul A. Jones hold at USANA (USNA)?

Paul A. Jones serves as Chief People Officer at USANA Health Sciences. This officer role is specifically identified in the Form 4, which reports his recent open-market sale of Common Stock shares.

Was the USANA (USNA) insider transaction a buy or sell?

The USANA insider transaction was a sale. The Form 4 lists transaction code “S,” indicating an open-market sale of 6,813 shares of Common Stock by Chief People Officer Paul A. Jones.